Taltz
Market Access/ News/ News/ News/ R&D/ Top stories
Novartis’ Cosentyx didn’t EXCEED Humira in psoriatic arthritis
Phil Taylor
AbbVie, Cosentyx, Eli Lilly, Humira, immunology, Novartis, psoriatic arthritis, Taltz
0 Comment
X
Novartis’ Cosentyx didn’t EXCEED Humira in psoriatic arthritis
https://pharmaphorum.com/news/novartis-cosentyx-cant-exceed-humira-in-psoriatic-arthritis/
News/ News/ Sales and Marketing/ Top stories
Lilly dips as biomed chief Christi Shaw heads to Gilead
Phil Taylor
Eli Lilly, Emgality, senior management, Taltz
0 Comment
X
Lilly dips as biomed chief Christi Shaw heads to Gilead
https://pharmaphorum.com/news/lilly-dips-as-biomed-chief-christi-shaw-heads-to-gilead/
Lilly’s Taltz scrapes win against Humira in psoriatic arthritis
Phil Taylor
Humira, Lilly, psoriatic arthritis, Taltz
0 Comment
X
Lilly’s Taltz scrapes win against Humira in psoriatic arthritis
https://pharmaphorum.com/news/lillys-taltz-scrapes-win-against-humira-in-psoriatic-arthritis/